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The MADS-box transcription factor MEF2 is expressed specifically in developing cardiac, somatic, and visceral muscle cell
lineages during Drosophila embryogenesis and is required for myoblast differentiation and muscle morphogenesis. To define
he mechanisms that regulate Mef2 transcription, we have analyzed the Mef2 upstream region for sequences sufficient to
recapitulate the expression pattern of the gene in Drosophila embryos. Here we describe a complex enhancer located 5.8 kb
pstream of the Drosophila Mef2 gene that controls transcription in cardial cells of the dorsal vessel, a subset of somatic
uscle founder cells, and the visceral muscle cells. The core of this enhancer contains two evolutionarily conserved binding
ites for the homeodomain protein Tinman (Tin), expressed in developing cardiac, somatic, and visceral muscle lineages.
oth Tin binding sites are required for enhancer activity in all three muscle cell lineages. Whereas the 285-bp enhancer core
lone is sufficient for expression in cardiac cells, expression in somatic founder cells and visceral muscle is dependent on
he core enhancer plus unique flanking sequences that include an evolutionarily conserved E box. These results reveal an
ssential role for Tin in activation of Mef2 transcription in multiple myogenic lineages and demonstrate that transcriptional
ctivity of Tin is dependent on combinatorial interactions with other factors unique to different muscle cell
ypes. © 1999 Academic Press
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Genetic studies in mice and Drosophila have revealed
important components of the regulatory circuitry involved
in specification and differentiation of skeletal, cardiac, and
visceral muscle cells and indicate that the signaling sys-
tems and transcription factors that control development of
these different muscle cell types are evolutionarily con-
served (Manak and Scott, 1994; Baylies et al., 1998). Dissec-
tion of the roles of individual myogenic regulatory factors is
complicated in vertebrates by functional redundancy
among related factors, whereas in Drosophila, regulatory
circuitry is simpler, with single genes controlling key steps
in myogenic pathways.
Specification of muscle cell lineages during Drosophila
embryogenesis occurs soon after gastrulation as the nascentb
T
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420esoderm along the ventral midline of the embryo invagi-
ates and becomes patterned in response to both intrinsic
nd extrinsic factors (Bate, 1993). The dorsalmost mesoder-
al precursors give rise to the cardiac cell lineage, which
orms a heart-like organ, known as the dorsal vessel, along
he dorsal midline. Visceral mesoderm, which ultimately
ives rise to the visceral musculature of the gut, is also
erived from a subpopulation of dorsal mesodermal cells,
hile somatic muscle originates from both dorsal and
entral mesoderm (Azpiazu et al., 1996; Riechmann et al.,
997). Somatic muscle formation occurs as somatic founder
ells recruit adjacent mesodermal cells to the somatic
ineage through formation of syncytia that go on to form a
tereotypical pattern of 30 skeletal muscle fibers reiterated
n each hemisegment along the anterior–posterior axis of
he embryo (Bate, 1990; Rushton et al., 1995).
Mesoderm formation in Drosophila is controlled by the
asic helix-loop-helix (bHLH) factor Twist (Leptin, 1991).
hereafter, subdivision of the mesoderm into different
0012-1606/99 $30.00
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between several mesoderm-restricted transcription factors
and growth factor-mediated signaling pathways. The ho-
meobox gene tinman (tin) is first expressed in all mesoder-
al precursor cells at the blastoderm stage. As mesodermal
ells invaginate and spread laterally during gastrulation
stage 7), tin expression becomes restricted to the dorsal
mesoderm in response to signaling by the transforming
growth factor-b-like peptide Decapentaplegic (Frasch,
1995). At this stage, tin expression marks cardiac and
visceral muscle precursors, as well as a subset of dorsal
somatic muscle precursors. Later, by stage 12, tin expres-
ion is restricted to cardial cells of the dorsal vessel (Az-
iazu and Frasch, 1993; Bodmer, 1993). In tin mutant
mbryos, the cardiac, visceral, and dorsal somatic muscle
ineages do not form, indicating that one of the functions of
in is to specify these lineages (Azpiazu and Frasch, 1993;
odmer, 1993). Within the visceral muscle lineage, tin is
essential for activation of the related homeobox gene bag-
pipe (bap), required for specification of visceral muscle cells
(Azpiazu and Frasch, 1993). Given the persistence of tin
expression in the dorsal vessel, it is likely tin plays roles in
activation of cardiac muscle structural genes, in addition to
its role in cardiac specification. Very few target genes for
Tin have been identified and it is unknown whether Tin
activates the same or entirely different genes in each
myogenic developmental pathway.
Members of the MEF2 family of MADS-box transcription
factors bind the control regions of the majority of muscle-
specific genes and play central roles in myogenesis and
morphogenesis of all muscle cell types (reviewed in Black
and Olson, 1998). In vertebrates, there are four mef2 genes,
mef2A, -B, -C, and -D, expressed throughout development
of each myogenic lineage. Similarly, in Drosophila, the
single Mef2 gene, D-mef2, is also expressed in all develop-
ing muscle cell lineages and their differentiated descen-
dants (Lilly et al., 1994; Nguyen et al., 1994; Taylor et al.,
995). Loss-of-function mutations in D-Mef2 prevent differ-
ntiation of cardiac, skeletal, and visceral muscle cells, but
o not affect myoblast specification or positioning in the
mbryo (Lilly et al., 1995; Bour et al., 1995; Ranganayakulu
et al., 1995), revealing a shared dependence of all muscle
cell types on MEF2 for late steps in development. The
highly conserved expression patterns, structure, and tran-
scriptional activity of MEF2 factors from vertebrates and
fruit flies imply a conserved role in muscle development.
Indeed, mice lacking MEF2C show severe abnormalities in
cardiac and smooth muscle development (Lin et al., 1997,
1998; Bi et al., 1999). However, because of functional
redundancy among the different mef2 genes, it has not yet
been possible to generate mice completely lacking MEF2
activity.
While numerous transcriptional targets of MEF2 factors
have been identified (Black and Olson, 1998), little is
known of the regulatory factors that act upstream of Mef2
genes in developing muscle cell lineages. This problem has
been difficult to address in vertebrates, in which the 59
Copyright © 1999 by Academic Press. All rightuntranslated regions of the four Mef2 genes contain mul-
tiple alternatively spliced exons separated by large introns
and the precise transcriptional initiation sites have not
been determined (B. Black and E. Olson, unpublished). In
contrast, the complete intron/exon organization of the
Drosophila Mef2 gene has been defined and the 13 kb of
DNA immediately upstream of the gene has been shown to
be sufficient to direct the entire muscle-specific expression
pattern during embryogenesis. Within this upstream region,
at least a dozen independent transcriptional enhancers have
been identified, each of which regulates transcription of the
gene in a subset of developing muscle cells in the embryo
(Lilly et al., 1995; Schulz et al., 1996; Gajewski et al., 1997,
1998; Cripps et al., 1998; Nguyen and Xu, 1998).
The early expression of D-Mef2 in the mesoderm is
similar to that of tin. Both genes are coexpressed in the
nascent ventral mesoderm and are activated by Twist
(Taylor et al., 1995; Yin et al., 1997; Lee et al., 1997; Cripps
et al., 1998). Subsequently, as the mesoderm becomes
subdivided, ultimately giving rise to cardiac, visceral, and
somatic muscle lineages, Mef2 expression is maintained in
all myogenic cells, whereas tinman becomes restricted to
dorsal mesodermal cells before becoming completely re-
stricted to the dorsal vessel.
Previously, we and others have identified an enhancer,
located about 5.8 kb upstream of D-Mef2, that controls
transcription in cardial cells of the dorsal vessel (Schulz et
al., 1996; Gajewski et al., 1997, 1998; Nguyen and Xu,
1998). This enhancer contains two binding sites for Tin,
both of which are required for transcriptional activity in the
cardiac lineage. Since Tin is also required for differentiation
of visceral and somatic muscle lineages, we sought to
determine whether the Tin binding sites in the cardial cell
enhancer might also regulate Mef2 expression in these
lineages. Here we show that the Tin-dependent cardial cell
enhancer is the central module of a more complex regula-
tory region that utilizes combinations of adjacent se-
quences to activate Mef2 transcription in visceral muscle
and somatic founder cells. Our results reveal a combinato-
rial mechanism for control of Mef2 transcription and dem-
onstrate a shared dependence of cardiac, visceral, and so-
matic muscle cell lineages on Tin for activation of Mef2
transcription.
MATERIALS AND METHODS
Generation and analysis of enhancer constructs. Mef2
genomic fragments for enhancer analysis were generated either by
restriction digestion (constructs 1–3, Fig. 1) or by polymerase chain
reaction (PCR) using specific oligonucleotide primers, as follows:
construct 4, bin 98 (59-AAAATCATGTTCTTTAACAAAT-39) and
bin 79 (59-CCAGCTTCATAATACGAGGCACGTG-39); construct
5, bin 105 (59-CGCTTCGGTTGGCTTTAGGTGA-39) and bin 107
(59-GAAGCCGCAAACAAAGCCACTGGAT-39); construct 6, bin
105 and bin 86 (59-CCTCGCACTTCCATTAAGAATTGCT-39);
construct 7, bin 105 and bin 104 (59-AATCTTTACACCCCT-
GACCT-39); construct 8, bin 105 and bin 103 (59-AGATACTCAG-
s of reproduction in any form reserved.
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TCCTAAACAGATACAGATACAGAAACAGAAAC-39) and
in 107; construct 10, bin 115 and bin 112 (59-GGCACATTTC-
CCGGTCTGGATGGACG-39); construct 11, bin 155 (59-
GCCGCGGATAAGGGGCTCAAGTGGCTTGGGTGC-39—
italics refer to sequence which does not match Mef2 sequences) and
bin 107; construct 12, bin 162 (59-TAGATATGCTAT-
TTGATTTCTGGCTCGGC-39) and bin 107; and construct 13, bin
170 (59-ATGTGCCTCATTTGGCTTGGGAT-39) and bin 107.
Products were cloned into the CaSpeR-hsp43-AUG-b-gal
(CHAB) P-element transformation vector, which contains a lacZ
eporter gene downstream of a minimal hs43 heat-shock promoter
Thummel and Pirrotta, 1992). P-element-mediated germ-line
ransformation was performed essentially as described by Rubin
nd Spradling (1982). Embryos of the genotype y w were coinjected
ith the CHAB constructs and a 2-3 helper plasmid (Robertson et
l., 1988), and transgenic adults were identified in the G1. Inde-
endent lines were maintained by backcrossing to y w and select-
ng for the darker eye color of homozygotes in subsequent genera-
ions. For each enhancer sequence tested, a minimum of three
ndependent lines were analyzed. Flies were raised at 25°C on
tandard cornmeal–glucose–yeast agar medium. Enhancer–lacZ
ines were crossed into tinEC40 and bap208 mutant backgrounds using
tandard genetic techniques. tin and bap mutants were provided by
. Frasch (Mount Sinai School of Medicine, New York).
Cloning of the Drosophila virilis Mef2 gene and its flanking
equences. Initial cloning of the D. virilis Mef2 gene was de-
cribed in Cripps et al. (1998). Bacteriophage clones containing
additional upstream sequences were isolated from a D. virilis
genomic library made by J. Tamkun and provided by S. Wasserman,
using a 59 probe made from existing D. virilis genomic clones
(Cripps et al., 1998). Sequencing of the 59 flanking region of the D.
virilis Mef2 gene and of PCR-generated mutant constructs was
carried out with an ABI 373 automated sequencer.
Immunohistochemistry of Drosophila embryos. Embryos at
specific time points were collected from agar plates containing
grape juice. Immunohistochemistry of whole-mount embryos was
carried out as described (Patel et al., 1987). The primary antibody
was an anti-b-galactosidase monoclonal antibody from Promega
(1:400 dilution); localized primary antibody was detected using the
Vectastain Elite Staining Kit (Vector Laboratories, CA). Stained
embryos were cleared and mounted in 80% (v/v) glycerol for
imaging.
PCR-based site-directed mutagenesis. Mutagenesis of the
Mef2 enhancer was carried out by PCR-based site-directed mu-
tagenesis (Horton, 1993). Oligonucleotides with mutated Tin bind-
ing sites were used in a 30-cycle standard PCR to generate primary
products. Purified primary products were then annealed and used as
templates for secondary PCR using either TaKaRa LA Taq from
anVera or Extended Taq from Boehringer Mannheim. The distal,
in1, sequence was mutated using the oligonucleotides Bin-tin-
-5-3 (59-TAAGGGGCGCCCGGGGCTTGGGTGCCTCCATT-
CCG-39) and Bin-tin-1-3-5 (59-CGGAATGGAGGCACCCAAGC-
CCCGGGCGCCCCTTA-39) (underlined sequences indicate changes
from the wild-type sequence). The proximal, Tin2, site was mu-
tated using the oligonucleotides Bin-tin-2-5-3 (59-GCAGCTAAAG-
GATGCGCCCGCCCGGGACCGGGCTCGCT-39) and Bin-tin-2-
3-5 (59-AGCGAGCCCGGTCCCGGGCGGGCGCATCCTTTA-
GCTGC-39) (underlined sequences indicate changes from the
wild-type sequence). Oligonucleotides containing these sequences
were incapable of competing with the wild-type sequence for Tin
binding in an electrophoretic gel mobility shift assay, indicating
Copyright © 1999 by Academic Press. All rightthat they were incapable of binding the Tin protein (data not
shown). The E box was mutated using the oligonucleotides Bin 159
(59-GGGAAATGTGCCTCTCGAGGCTTGGGAT-39) and Bin 160
(59-GGAAATCCCAAGCCTCGAGAGGCACATT-39) (underlined
sequences indicate changes from the wild-type sequence).
RESULTS
Localization of a cardiac, somatic, and visceral muscle
regulatory region upstream of Mef2. Previous studies
showed that a region from 29120 to 23560 bp upstream of
Mef2 contains elements sufficient to direct transcription in
cardiac and visceral muscle lineages, as well as in a subset
of somatic founder cells, during embryogenesis (Schulz et
al., 1996) and that a 237-bp region from 25907 to 25670 is
active only in cardial cells of the dorsal vessel (Gajewski et
al., 1997). This cardial cell enhancer contains two Tin
binding sites essential for transcriptional activity.
In an effort to segregate the regulatory regions required
for cardiac, somatic, and visceral muscle expression, we
subdivided the 29120/23560 region (construct 1, Fig. 1) in
half and tested for enhancer activity in vivo in transgenic
flies, using a lacZ reporter construct. Although both halves
of construct 1 were able to direct expression of the lacZ
transgene in the dorsal vessel, only the downstream region
(25942/23560), containing the Tin-dependent enhancer,
showed activity in cardiac precursor cells (constructs 2 and
3, Fig. 1). Furthermore, the downstream half also was
capable of driving lacZ expression in somatic founder and
visceral muscle precursor cells.
Further deletions showed that cardiac, as well as visceral
and somatic, muscle expression were controlled by nucle-
otides 25990 to 25180 (construct 5, Fig. 1), containing the
previously characterized cardial cell enhancer (Gajewski et
al., 1997, 1998). Transcriptional activity of this region was
first detected at stage 10 in dorsal and ventral clusters of
cells coincident with the positions of precursors of the
dorsal vessel and a subset of two to three somatic muscle
founder cells, respectively (Fig. 2A). Shortly thereafter,
reporter gene expression was also detected in precursor cells
of the visceral musculature (Fig. 2B). Expression in somatic
and visceral muscle cells was maintained through stage 12
(Fig. 2C). Subsequently, as differentiation proceeded, ex-
pression was lost from somatic and visceral muscle cells,
but high levels of enhancer activity persisted in a segmen-
tally repeating pattern within cardial cells of the dorsal
vessel (Fig. 2D).
The dorsal vessel contains six pairs of cardial cells within
each hemisegment. The 810-bp cardiac enhancer (construct
5) was active in four of these six pairs of cells, corresponding
to the expression pattern of Tin (Jagla et al., 1997). A larger
enhancer region encompassing construct 5 was also re-
cently shown to direct expression in precisely the same
cells that express Tin (Nguyen and Xu, 1998). In contrast,
the more distal upstream region (construct 2) directed lacZ
expression in the other two cardial cell pairs within each
s of reproduction in any form reserved.
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shown).
FIG. 1. Deletion mutations define a region sufficient for cardiac, vis
and upstream region are schematized and regions of 59 DNA tested fo
enhancer (25907/25670) is indicated in red. Cell types in which lacZAlthough enhancer activity in the somatic and visceral
muscle lineages was transient, mirroring the expression pat-
expression is observed in somatic founder cells (sf), cardial precursor c
muscle (vsm and vm, respectively), and dorsal vessel (dv).
Copyright © 1999 by Academic Press. All rightern of Tin in these cells, we were able to use the perdurance
f b-galactosidase to identify the muscles that formed from
, and somatic muscle expression of Mef2. The Drosophila Mef2 gene
ancer activity are indicated. The location of the minimal cardial cell
sgene expression was observed are shown. P, PstI site; R, EcoRI site.cells in which the enhancer was active. In the somatic lineage,
these corresponded to muscles V04, V05, and V06 (Bate, 1993).FIG. 2. Expression pattern directed by construct 5. Embryos bearing construct 5 (see Fig. 1) were stained for lacZ expression at stages 10
(A), 11 (B), 12 (C), and 14 (D). Anterior is to the left in all cases. Each panel shows a lateral view, except D, which is a dorsal view. LacZells (cp), visceral precursor cells (vp), ventral somatic and visceral
s of reproduction in any form reserved.
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tory elements. The consensus DNA sequence for Tin
inding is T(C/T)AAGTG (Chen and Schwartz, 1995). The
37-bp cardial cell enhancer (25907/25670), encompassed
by construct 5, contains two Tin binding sites, required for
enhancer activity in cardial cells (Gajewski et al., 1997).
This minimal enhancer shows the same temporospatial
expression pattern in the cardiac lineage as construct 5, but
it is inactive in visceral and somatic muscle cell lineages.
This indicates that sequences in addition to the core cardiac
enhancer are required for expression in the somatic and
visceral musculature.
To further define the boundaries of the cardiac, visceral,
and somatic muscle regulatory elements within the 25990/
25180 region (construct 5), we created a further series of
deletion mutations. Deletions from the 39 side to 25322,
25517, or 25627 (constructs 6, 7, and 8, Fig. 3) had no effect
on enhancer activity in any myogenic lineage. Deletion
from the 59 end to 25940 (construct 9) also did not affect
cardiac, visceral, or somatic expression. However, com-
bined 59 and 39 deletions to create a 285-bp enhancer
(25940/25656; construct 10) eliminated activity in visceral
and somatic founder cells, without affecting expression in
the cardiac lineage (Fig. 3). Since 59 deletion to 25940
within the context of the larger region had no effect on
enhancer activity (construct 9, 25940/25180), we conclude
FIG. 3. Deletion mutations surrounding the Tin-dependent enhan
ranscription. Deletion mutations were introduced into construct
expression. The location of the minimal cardial cell enhancer (2
expression was observed are shown. R, EcoRI site; E, E box; T1 anthat the region between 25656 and 25627 is essential for
somatic and visceral muscle expression and not for expres-
Copyright © 1999 by Academic Press. All rightsion in cardial muscles. Interestingly, this region contains
an E box, conserved in D. melanogaster and D. virilis (see
below).
Deletion from the 59 end to 25898 eliminated expression
in visceral muscle without affecting expression in cardial or
somatic founder cells (Fig. 3, construct 11). These results
indicated that sequences between 25940 and 25898 were
essential for enhancer activity in visceral, but not cardiac or
somatic, muscle lineages. Further 59 deletion to 25808
(construct 12), which eliminated one Tin binding site,
abolished expression in all muscle cell types. An additional
construct deleted from the 59 end to 25662 (construct 13)
was also inactive.
These deletion mutations indicated that sequences
within and surrounding the minimal Tin-dependent en-
hancer region (25907/25670) were required for expression
in cardiac, somatic, and visceral muscle lineages. While
cardiac expression was achieved with the enhancer core
alone, somatic expression was dependent on sequences
downstream of the core enhancer and visceral expression on
sequences surrounding the core enhancer. Thus, the region
between 25940 and 25627 functioned as a composite
enhancer utilizing overlapping, but distinct, sequences for
expression in different muscle cell types.
Homology between D. melanogaster and D. virilis en-
hancers. To guide us in identifying regulatory elements
eveal sequences required for cardiac, visceral, and somatic muscle
5990/25180) and tested for enhancer activity by staining for lacZ
/25670) is indicated in red. Cell types in which lacZ transgene
, Tin binding sites.cer r
5 (2within the Mef2 upstream region that might be essential for
enhancer activity, we sequenced the 13-kb region immedi-
s of reproduction in any form reserved.
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425Transcription of Mef2 Is Regulated by Tinmanately preceding the Mef2 gene from D. virilis and searched
for cis-acting sequences sufficient to direct expression in
cardiac, visceral, and somatic muscle cell lineages. Using an
overlapping series of DNA fragments spanning the up-
stream region, we identified a D. virilis genomic region
from 29894 to 29094 that directed muscle-specific expres-
sion of lacZ in a pattern similar to that of the minimal
810-bp composite enhancer from D. melanogaster (Fig. 4A).
he D. virilis fragment also controlled expression in addi-
ional regions of the mesoderm (Fig. 4A and data not
hown), and therefore likely contains additional enhancers.
By comparing the sequence of the minimal D. melano-
aster composite enhancer (construct 8, Fig. 3) with that of
. virilis, we identified five blocks of conserved sequence
termed A–E, Fig. 4B). Of note, both Tin binding sites
regions B and D) were conserved in the two species. The
egion immediately 59 of the Tin1 site (region A), corre-
ponding to the region shown to be essential for enhancer
ctivity in visceral muscle, was also conserved. There was
nly a short region of homology between the Tin binding
ites (region C). Sequence similarity between D. melano-
aster and D. virilis was also striking in a region 38
nucleotides downstream of the Tin2 site (region E). Al-
though this region is not required for cardial enhancer
activity, this segment of homology corresponds with the
region we found to be required for expression in visceral
muscle and somatic founder cells. This conserved region
contained an E box (CANNTG), the consensus binding site
for bHLH proteins.
Recently, it was reported that mutation of a GATA site in
the D. melanogaster Mef2 enhancer located immediately 39
of the Tin2 site changed specificity of the enhancer from
cardial cells of the dorsal vessel to pericardial cells (Gajew-
ski et al., 1998). This GATA site is not conserved in D.
virilis, nor are there other GATA sites nearby, making its
functional significance unclear.
Requirement of the Tin sites for cardiac muscle, visceral
muscle, and somatic founder cell enhancer activity. To
investigate the potential roles of conserved sequences in the
composite cardiac, visceral, and somatic regulatory region,
we mutated each Tin site singly and in combination within
the context of the 810-bp enhancer (construct 5). Mutation
of the Tin1 site resulted in dramatic reduction in lacZ
expression in all muscle lineages (Fig. 5). LacZ expression
was undetectable in visceral muscle precursors and only
weakly detectable in a few cardiac and somatic muscle cells
with this mutant enhancer. Mutation of the Tin2 site also
severely reduced enhancer activity, with only very low
levels of b-galactosidase detectable in some regions of the
idgut (Fig. 5). The enhancer with both Tin sites mutated
howed the same expression pattern as the Tin2 mutant
Fig. 5). These results demonstrate a similar dependence of
ll three myogenic lineages on occupancy of both Tin sites
n the enhancer core for transcriptional activity.
Requirement of the E box for visceral muscle and so-
atic founder cell enhancer activity. The deletion anal-
ses indicated that the evolutionarily conserved region
Copyright © 1999 by Academic Press. All rightmmediately 39 of the Tin-dependent enhancer core, con-
aining the E box, was required for enhancer activity in
isceral muscle and somatic founder cells. To address the
unctional significance of this E box, we mutated it within
onstruct 5 and tested enhancer activity in vivo (Fig. 5).
trikingly, this mutant enhancer showed no activity in
isceral or somatic muscles at any stage of embryogenesis,
evealing an essential role for the conserved E box in Mef2
xpression in those muscle lineages. However, this mutant
nhancer was fully active in the cardiac muscle lineage,
ndicating a specific requirement for the E box in visceral
nd somatic muscle transcription of Mef2. These findings
re consistent with our deletion analysis in which we found
hat 39 deletion to 25656 (Fig. 3, construct 10), which
emoves this conserved region, resulted in a loss of en-
ancer activity in the somatic and visceral lineages, but not
n the cardiac lineage.
The composite enhancer requires Tin and is indepen-
ent of Bap. The mutational analyses demonstrated that
nhancer activity in all three muscle cell lineages was
ependent on the two Tin sites, making it likely that Tin or
related homeodomain protein was the activator of Mef2
ranscription in these lineages. To further address this, we
xamined expression of the enhancer (25990/25627, con-
truct 8) in tin mutant embryos (Fig. 6). Absence of tin
unction resulted in a loss of enhancer activity in all cells
hroughout embryogenesis, reflecting the essential role of
in in enhancer activation (Fig. 6).
In the visceral muscle lineage, Tin is required for expres-
ion of the related homeodomain protein, Bap (Azpiazu and
rasch, 1993). Therefore, we also tested enhancer activity in
ap mutant embryos to determine if the effect of loss of Tin
unction reflected a direct role of Tin as an activator of the
nhancer or an indirect role mediated by Bap. Although the
isceral mesoderm barely forms in Bap mutants, lacZ
xpression was clearly detected at high levels in all three
uscle lineages in bap mutant embryos (Fig. 6). We con-
lude that the composite enhancer is specifically activated
y Tin in cardiac, visceral, and somatic muscle cell lin-
ages.
DISCUSSION
Through analysis of the Mef2 upstream region, we have
defined a Tin-dependent enhancer responsible for Mef2
transcription in cardiac, somatic, and visceral muscle cell
lineages during Drosophila embryogenesis. This is, to our
knowledge, the only example of a specific target enhancer
for Tin involved in gene activation within all three muscle
cell lineages. The requirement of this enhancer for sur-
rounding sequences that differ for each muscle cell type
suggests that Tin acts combinatorially with other regula-
tory factors to control muscle-lineage-restricted patterns of
transcription. Consistent with this conclusion, previous
studies have suggested that the N-terminus of Tin interacts
s of reproduction in any form reserved.
426 Cripps, Zhao, and OlsonFIG. 4. Enhancer activity of D. virilis upstream region and sequence homology with D. melanogaster. (A) The expression pattern of lacZ
in D. melanogaster embryos directed by a region upstream of the Mef2 gene from D. virilis. Left, stage 11 embryo, lateral view. Right, stage
15 embryo, dorsal view. Expression is observed in cardial precursors (cp), visceral muscle (vm), somatic founder cells (sf), and dorsal vessel
(dv), as well as in somatic muscle cells (marked in right). (B) Nucleotide sequence homology between the enhancer region for cardiac,
somatic, and visceral expression from D. melanogaster and D. virilis. A schematic of the enhancer is shown at the top and regions of
homology are shown below. Region A is essential for visceral expression and region E for visceral and somatic.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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nayakulu et al., 1998).
Combinatorial control of Mef2 transcription by Tin.
he Tin-dependent Mef2 enhancer is a composite of over-
apping cis-regulatory elements, which rely on the centrally
FIG. 5. Mutational analysis of Tin sites and an E box in the comp
ithin construct 5 were mutated and tested for activity in vivo. Cel
views of stage 12 embryos bearing the transgene constructs depicte
vessel; sf, somatic founders; vm, visceral musculature.
FIG. 6. Expression of the composite enhancer in tin and bap mut
C, D), and bap mutant (E, F) embryos is shown at stages 12 (A, C, E) an
ut retains activity in bap mutants. cp, cardial precursors; sf, somatic f
Copyright © 1999 by Academic Press. All rightocated Tin binding sites for activation in different muscle
ell lineages (Fig. 7). Enhancer activity in all muscle cell
ypes requires both Tin sites in the enhancer core. How-
ver, each muscle cell type differs with respect to other
nhancer sequences required for transcriptional activity. In
enhancer. (A) The Tin sites and E box in the composite enhancer
s in which enhancer activity was detected are indicated. (B) Lateral
A and stained for lacZ are shown. cp, cardial precursors; dv, dorsal
mbryos. Expression of construct 5 in wild-type (A, B), tin mutantosite
l typeant e
d 13 (B, D, F). The enhancer is completely inactive in tin mutants
ounders; vm, visceral musculature, dv, dorsal vessel.
s of reproduction in any form reserved.
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that include an evolutionarily conserved E box are required
for activity. In contrast, visceral expression requires se-
quences immediately 59 of the enhancer core, in addition to
the 39 E box necessary for somatic muscle expression.
Cardiac expression requires only the enhancer core, with no
apparent role of surrounding sequences.
Although Bap is expressed in visceral mesoderm and is
structurally related to Tin, it is not required for activation
of the Tin-dependent enhancer in the visceral mesoderm, as
demonstrated by the normal level of enhancer activity in
bap mutant embryos. While we favor the conclusion that
Tin is the true activator of the Mef2 enhancer in cardiac,
somatic, and visceral muscle cells, it is formally possible
that another factor that binds the Tin sites in the enhancer
core is the actual activator of the enhancer. However, if this
was the case, such a factor would have to act downstream of
Tin in each myogenic lineage since enhancer activity in all
muscle cell types was abolished in tin mutant embryos. It is
also interesting to note that while Tin is required for
activation of the enhancer described here in cardiac, so-
matic, and visceral muscle cell lineages, there are also
multiple Mef2 enhancers active in each of these lineages
that do not contain Tin binding sites.
During this work, another study showed that mutations
of both Tin sites together in the Mef2 enhancer abolished
expression in cardiac and somatic muscle and that the E box
was also required for somatic expression (Gajewski et al.,
1998). However, the potential roles of individual Tin sites
were not investigated and the ability of the enhancer to
direct expression in visceral muscle was not demonstrated,
nor was the homology to D. virilis identified. Taken to-
FIG. 7. Schematic diagram of regions of the composite enhancer re
or transcription in each muscle cell lineage are shown beneath thgether, both our studies and those of Gajewski et al. define
a novel, evolutionarily conserved enhancer required for
Copyright © 1999 by Academic Press. All rightTin-dependent transcriptional activation in multiple
muscle cell lineages.
E-box-dependent regulation of somatic and visceral
muscle transcription. We do not currently know the iden-
tity of the factor that binds the evolutionarily conserved E
box required for somatic and visceral expression, but a
bHLH protein would be a likely candidate. The MyoD-like
factor nautilus is expressed in a subset of somatic founder
cells (Michelson et al., 1990; Paterson et al., 1991), but it is
not expressed in visceral muscle. The bHLH factor lethal-
of-scute (L’sc) is also expressed in somatic founder cells
(Carmena et al., 1995), but the Tin-dependent enhancer is
active in L’sc mutant embryos (unpublished results), ruling
out a role for this bHLH factor in enhancer activation. The
factor bHLH54 is also expressed in a subset of somatic and
visceral muscle precursors (Georgias et al., 1998). However,
neither bHLH54 nor any of the other bHLH factors men-
tioned above bind the E box from the Mef2 composite
enhancer (J. Lu and E. Olson, unpublished results). Twist is
also expressed in early mesodermal precursors of visceral
and somatic muscle, but recent studies showed that it
represses activity of this Mef2 upstream region (Gajewski et
al., 1998). Thus, no known bHLH factor appears likely to
act through the essential E box in the enhancer.
Modular regulation of Mef2 transcription. The Dro-
sophila Mef2 gene is regulated by an extraordinary number
of independent transcriptional enhancers that demarcate
specific myogenic lineages during embryogenesis. To date,
at least 12 independent Mef2 enhancers have been identi-
fied, but only a few have been characterized with respect to
their upstream activators. We showed that transcriptional
activation of Mef2 in the embryonic mesoderm and in adult
ed for expression in different myogenic cell types. Regions required
ematic of the overall genomic region.somatic muscle precursors requires binding of Twist to an
evolutionarily conserved E box in a 175-bp enhancer located
s of reproduction in any form reserved.
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429Transcription of Mef2 Is Regulated by Tinman2.2 kb upstream of the gene (Cripps et al., 1998). An
additional Mef2 enhancer has also been shown to be a target
for activation by Dpp signaling (Nguyen and Xu, 1999). This
enhancer is activated by Medea, a Smad protein that acts
downstream of the Dpp receptor.
Modular regulation of muscle genes, as exemplified by
the complex arrangement of independent cis-regulatory
modules upstream of Mef2, is emerging as a common theme
in muscle gene regulation (Firulli and Olson, 1997). This
type of regulation enables a regulatory gene, such as Mef2,
to integrate a diverse array of inputs throughout develop-
ment and may also provide a foundation for evolution of
specialized programs of gene expression through addition of
independent transcriptional regulatory elements to a more
primitive control region.
In this regard, while it has been well documented that the
hearts of vertebrates are patterned along the anteroposterior
axis into populations of precursor cells that may use differ-
ent transcriptional regulatory programs (reviewed in Olson
and Srivastava, 1996), it is not generally appreciated that
the dorsal vessel in Drosophila may also be segmentally
patterned. Such patterning is revealed by the expression of
Tin and the core cardial cell enhancer in six of eight pairs of
cardial cells in each hemisegment along the anteroposterior
axis. Activation of Mef2 transcription in the remaining two
cardial cell pairs within each hemisegment is dependent on
more distal 59 flanking sequences (contained in construct 2,
Fig. 1). It will be of particular interest to identify the factors
that bind this Tin-independent regulatory region to confer
cardial cell expression.
Evolutionary conservation of myogenic regulatory path-
ways. Our results raise interesting questions about evolu-
tionary conservation of myogenic regulatory mechanisms.
In Drosophila, tin is the only NK-type homeobox gene
known to be required for cardiogenesis. Likewise, the
closely related gene, ceh-22, from Caenorhabditis elegans,
is required for development of pharyngeal muscle, which is
functionally related to cardiac (Okkema and Fire, 1994).
Moreover, tin can substitute for ceh-22 to support pharyn-
geal muscle development in C. elegans, consistent with an
evolutionarily conserved role of these homeobox genes in
muscle formation (Huan et al., 1998). Mouse Nkx2-5 can
also substitute for tin to support visceral but not cardiac
muscle development in Drosophila (Ranganayakulu et al.,
1998). In vertebrates, there are multiple NK-2-class ho-
meobox genes (reviewed in Harvey, 1996). Nkx2-5, the most
extensively studied (Komuro and Izumo, 1993; Lints et al.,
1993), is required for morphogenesis of the heart tube and
activation of a subset of cardiac contractile protein genes
(Lyons et al., 1995). However, it is not required for specifi-
cation of cardiac identity, suggesting that other related
genes expressed in the heart can also perform this function.
Considering the similarity in expression patterns of Mef2
genes in fruit flies and vertebrates, it is tempting to specu-
late that the regulatory factors responsible for Mef2 expres-
sion will also be evolutionarily conserved and that NK-2-
class homeodomain proteins may also activate Mef2 gene
Copyright © 1999 by Academic Press. All rightexpression in multiple muscle cell lineages in vertebrates.
By taking a cross-species approach to define the functions
and regulation of Mef2 genes, we hope to uncover funda-
mental regulatory circuitry responsible for development of
different muscle cell types during embryogenesis.
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